Abstracts and Articles

Vagal Blocking for Obesity Control (VBLOC) : Interim Six Month Results in an Ongoing Trial Using a Second Generation System

Authors: Toouli MD, B Kulseng MD, U Keller MD, L Kow MD, R Marvik MD, G Johnsen MD, D M Frey MD, K S Tweden PhD, R R Wilson MD, C J Billington MD, Flinders Medical Centre Norway; University Hospital, Basel, Switzerland; EnteroMedics Inc., St. Paul, MN, US; University of Minnesota, Minneapolis, MN, USA

NAASO 2007: Vagal Blocking for Obesity Control (Vbloc): Plasma Pancreatic Polypeptide (PPP) Response to a Standardized Sham Meal Challenger

Authors: Michael Camilleri, Miguel Herrera, Lilian Kow, Juan Pablo Pantoja, James Toouli, Charles Billington, James Freston, Mark Knudson, Mark Vollmer, Richard Wilson, Katherine Tweden

IFSO 2007: Vagal Blocking for Obesity Control (VBLOC): Effects on Excess Weight Loss, Calorie Intake, Satiation and Satiety

Authors: James Toouli, MD, Jane Collins, MD, Charles Billington, MD, Mark Knudson, PhD, Chris Pulling, MD, Katherine S. Tweden, PhD, Mark Vollmer, Richard R. Wilson, MD, and Lilian Kow, MD

IFSO 2007: Vagal Blocking for Obesity Control (VBLOC): An Open-label Study of an Implantable, Programmable Medical Device to Treat Obesity

Authors: Lilian Kow, MD, Miguel Herrera, MD, B. Kulseng , R. Marvik, MD, Juan Pablo Pantoja, MD, Mehran Anvari, MD, Michael Bierk ,MD, James Freston, MD, M. Knudson, PhD, Katherine Tweden, PhD, Mark Vollmer, Richard R. Wilson, MD, and James Toouli, MD

SAGES 2007: Vagal Blocking for Obesity Control (VBLOC Therapy): Rechargeable and RF-coupled Technology Platforms

Authors: Mark B. Knudson , PhD, Adrianus Donders, MS, and Mark R. Stultz, MS, EnteroMedics Inc.

ASBS 2006: Vagal Blocking for Obesity Control (VBLOC): Studies of Pancreatic and Gastric Function and Safety in a Porcine Model.

Authors: K. Tweden, M. Sarr, M. Bierk, M. Camilleri, M. Kendrick, M. Knudson, F. Moody, R. Wilson and M. Anvari

DDW 2006: Vagal Blocking for Obesity Control (VBLOC): Concordance of Effects of Very High Frequency Blocking Current at the Neural and Organ Levels Using Two Preclinical Models

Authors: K. S. Tweden, M. Anvari, M. D. Bierk, C. J. Billington, M. Camilleri, C. N. Honda, M. B. Knudson, D. E. Larson, R. R. Wilson and J. W. Freston.

SAGES 2006: Vagal Blocking for Obesity Control (VBLOC) Therapy: Pre-clinical Findings and Rationale Guiding the Development of the First Active Implantable System Designed to Neuroregulate Multiple Obesity Management Mechanisms

Authors: Mark B. Knudson , PhD, Richard R. Wilson, MD, Adrianus Donders , MS

 

 

Home | What is VBLOC^TM Therapy? | Why VBLOC^TM Therapy?
Bariatric Weight Loss Surgery | Investors | Careers | Privacy Policy

EnteroMedics - 2800 Patton Road - St. Paul, MN 55113
CAUTION: Investigational device. Limited by Federal law to investigational use.
This page revised November 2007.

©Copyright 2007 EnteroMedics. All rights reserved. Nothing in this site, including descriptions of treatments may be reproduced without written authorization from EnteroMedics.